- Home
- BGXX
as 07-26-2024 4:00pm EST
Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | FT. LAUDERDALE |
| Market Cap: | 49.3M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 992.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.15 - $0.90 | Next Earning Date: | 08-15-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Bright Green Corporation (BGXX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Stockwell Lynn | BGXX | Director10% Owner | Jun 5 '24 | Sell | $0.36 | 1,000,000 | $359,700.00 | 68,183,658 | SEC Form 4 |
Latest Bright Green Corporation News
BGXX Breaking Stock News: Dive into BGXX Ticker-Specific Updates for Smart Investing
MT Newswires
2 months ago
Bright Green Insider Sold Shares Worth $359,700, According to a Recent SEC Filing
GlobeNewswire
2 months ago
CEO UPDATE
GlobeNewswire
4 months ago
BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY.
GlobeNewswire
4 months ago
BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING
GlobeNewswire
5 months ago
Bright Green Corporation (BGXX) submits for historic DEA Registration for Production of Schedule I and Schedule II controlled substances.
GlobeNewswire
5 months ago
BRIGHT GREEN CORPORATION GAINS MOMENTUM FOR THEIR “DRUGS MADE IN AMERICA” PLATFORM WITH APPROVAL FOR THE RESEARCH, PRODUCTION AND MANUFACTURING OF ALL SCHEDULE I AND SCHEDULE II PLANT-BASED DRUGS
GlobeNewswire
5 months ago
BRIGHT GREEN CORPORATION ANNOUNCES CHANGES TO BOARD OF DIRECTORS
PR Newswire
6 months ago
ASHFORD HOSPITALITY TRUST PROVIDES UPDATE ON PLAN TO PAY OFF STRATEGIC FINANCING
Compare BGXX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BGXX Bright Green Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.